SMITH & NEPHEW PLC Smith & Nephew plc Share Price Sao Paulo
Equities
S1NN34
BRS1NNBDR009
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30 BRL | +11.48% |
|
+14.16% | +14.11% |
| 05/06 | UBS Upgrades Smith & Nephew to Buy from Neutral, Raises PT | MT |
| 05/06 | European blue-chips up ahead of likely rate cuts | AN |
| Sales 2024 * | 581.4Cr 3.08TCr 49TCr | Sales 2025 * | 612.36Cr 3.25TCr 51TCr | Capitalization | 1.15TCr 6.1TCr 96TCr |
|---|---|---|---|---|---|
| Net income 2024 * | 53Cr 279.34Cr 4.4TCr | Net income 2025 * | 69Cr 366.27Cr 5.77TCr | EV / Sales 2024 * | 2.43 x |
| Net Debt 2024 * | 261.37Cr 1.39TCr 22TCr | Net Debt 2025 * | 229.8Cr 1.22TCr 19TCr | EV / Sales 2025 * | 2.26 x |
| P/E ratio 2024 * |
23.2
x | P/E ratio 2025 * |
17.2
x | Employees | 18,452 |
| Yield 2024 * |
2.86% | Yield 2025 * |
3.22% | Free-Float | 99.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Smith & Nephew plc
More press releases
More news
| 1 day | +11.48% | ||
| 1 week | +14.16% | ||
| Current month | +14.16% | ||
| 1 month | +20.19% | ||
| 3 months | +13.64% | ||
| 6 months | +20.68% | ||
| Current year | +14.11% |
1 week
26.91
30.00
1 month
25.5430.00
Current year
24.4630.00
1 year
22.5030.00
3 years
22.5030.45
5 years
22.5030.45
10 years
22.5030.45
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 01/22/01 |
John Rogers
DFI | Director of Finance/CFO | 56 | 01/12 |
Alison Parkes
CMP | Compliance Officer | - | 01/99/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 01/17/01 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 14/23/14 |
Rupert Soames
CHM | Chairman | 63 | 26/23/26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/24/07 | 30 | +11.48% | 1 |
| 04/24/04 | 26.91 | +2.40% | 1 |
Delayed Quote Sao Paulo, June 08, 2024 at 01:40 am IST
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
25/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.21
USD
Average target price
16.45
USD
Spread / Average Target
+24.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.65% | 13TCr | |
| -4.86% | 830.28Cr | |
| +43.30% | 573.42Cr | |
| -22.44% | 468.81Cr | |
| +7.79% | 342.23Cr | |
| -17.26% | 254.23Cr | |
| -13.36% | 203.34Cr | |
| -16.39% | 185.78Cr | |
| -31.24% | 159.46Cr |
- Stock Market
- Equities
- SN. Stock
- S1NN34 Stock
